NewsBenzingaKeefe, Bruyette & Woods Maintains Underperform on Allstate, Raises Price Target to $241 Keefe, Bruyette & Woods Maintains Underperform on Allstate, Raises Price Target to $241 Benzinga 2026.11.10 12:18 (GMT+0) Open on Benzinga Other news Cantor Fitzgerald Maintains Neutral on Pebblebrook Hotel, Raises Price Target to $23 Cantor Fitzgerald Maintains Neutral on Host Hotels & Resorts, Raises Price Target to $27 Keefe, Bruyette & Woods Maintains Outperform on Palomar Hldgs, Raises Price Target to $172 Rosenblatt Maintains Buy on PubMatic, Raises Price Target to $25 Cantor Fitzgerald Maintains Overweight on Apple Hospitality REIT, Raises Price Target to $22 Gain Therapeutics Q3 EPS $(0.07) Beats $(0.12) Estimate